Why the study?
Does prasugrel reduce platelet reactivity compared to clopidogrel in Japanese STEMI patients undergoing PPCI?
Does prasugrel reduce platelet reactivity compared to clopidogrel in Japanese STEMI patients undergoing PPCI?
Answers are grounded in this paper and cite their sources.
In Japanese STEMI patients undergoing PPCI, a reduced-dose prasugrel regimen provides more potent platelet inhibition than clopidogrel as early as 3 hours post-loading dose.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rollini et al. (2016) conducted an editorial in ST-Segment Elevation Myocardial Infarction (STEMI) (n=78). Prasugrel vs. Clopidogrel (300 mg loading dose followed by 75 mg/day maintenance dose) was evaluated on Platelet reactivity measured by VerifyNow-P2Y12.
Synapse has enriched 10 related papers. Consider them for comparative context: